Plasma protein profiling in a stage defined pancreatic cancer cohort – Implications for early diagnosis

Pancreatic ductal adenocarcinoma (PDAC) is a disease where detection preceding clinical symptoms significantly increases the life expectancy of patients. In this study, a recombinant antibody microarray platform was used to analyze 213 Chinese plasma samples from PDAC patients and normal control (NC...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Oncol
Autors principals: Gerdtsson, Anna Sandström, Wingren, Christer, Persson, Helena, Delfani, Payam, Nordström, Malin, Ren, He, Wen, Xin, Ringdahl, Ulrika, Borrebaeck, Carl A.K., Hao, Jihui
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2016
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5423191/
https://ncbi.nlm.nih.gov/pubmed/27522951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2016.07.001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars